Transient nephrogenic diabetes insipidus accompanied by possible psychogenic polydipsia. 1995

H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
Department of Internal Medicine, University of Tsukaba, Japan.

A 50-year-old Japanese man had been suffering from polydipsia and polyuria for 2 months without any other specific symptoms. His daily urinary output reached 5 liters. On admission, no abnormalities of the kidneys, heart, thyroid, adrenals, pituitary or hypothalamus were detected by laboratory tests and MRI of the head. Pure psychogenic polydipsia was ruled out because his urine volume did not decrease sufficiently with 18 h of water deprivation and the subsequent injection of aqueous vasopressin. Plasma arginine vasopressin (AVP) levels against plasma osmolality remained within the normal range during the test. These results indicated that diabetes insipidus in this case was caused by renal insensitivity to AVP. The symptoms disappeared spontaneously, and marked improvement was observed in a second water deprivation test 1 month later, although the maximum urine concentration was still subnormal. The combination of both latent insufficiency of AVP secretion and impairment of the renal countercurrent system induced by psychogenic polydipsia was speculated as a possible mechanism for the transient nephrogenic diabetes insipidus in this case.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D004327 Drinking Behavior Behaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking (time intervals - onset and duration), frequency and satiety. Behavior, Drinking,Behaviors, Drinking,Drinking Behaviors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D014563 Urodynamics The mechanical laws of fluid dynamics as they apply to urine transport. Urodynamic
D018500 Diabetes Insipidus, Nephrogenic A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY. ADH-Resistant Diabetes Insipidus,Acquired Nephrogenic Diabetes Insipidus,Congenital Nephrogenic Diabetes Insipidus,Diabetes Insipidus Renalis,Diabetes Insipidus, Nephrogenic, Autosomal,Diabetes Insipidus, Nephrogenic, Type 1,Diabetes Insipidus, Nephrogenic, Type I,Diabetes Insipidus, Nephrogenic, Type II,Diabetes Insipidus, Nephrogenic, X-Linked,Nephrogenic Diabetes Insipidus,Nephrogenic Diabetes Insipidus, Type I,Nephrogenic Diabetes Insipidus, Type II,Vasopressin-Resistant Diabetes Insipidus

Related Publications

H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
April 1957, Wisconsin medical journal,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
October 1963, Munchener medizinische Wochenschrift (1950),
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
March 2022, Cureus,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
February 1987, The Journal of clinical psychiatry,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
August 1984, American journal of obstetrics and gynecology,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
August 1980, Nihon rinsho. Japanese journal of clinical medicine,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
January 1961, Orvosi hetilap,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
January 2001, Nihon Jinzo Gakkai shi,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
April 2006, The Veterinary clinics of North America. Equine practice,
H Sone, and K Kawai, and M Nishi, and S Shimakura, and C Bannai, and Y Kawakami, and M Odawara, and T Matsushima, and Y Okuda, and K Yamashita
January 1992, Indian pediatrics,
Copied contents to your clipboard!